日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adult-Onset Hypopigmented Mycosis Fungoides: A Systematic Review of Clinicopathologic, Immunophenotypic, and Therapeutic Characteristics

成人发病型色素减退性蕈样肉芽肿:临床病理学、免疫表型和治疗特征的系统评价

Kimak-Pielas, Agnieszka; Robak, Ewa; Robak, Tadeusz; Żebrowska, Agnieszka

Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors

接受 BTK 抑制剂治疗的患者的皮肤不良反应

Robak, Ewa; Robak, Tadeusz

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

在初治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中,Zanubrutinib 与 Bendamustine 和 Rituximab 的疗效比较:SEQUOIA 研究的中位 5 年随访结果

Shadman, Mazyar; Munir, Talha; Robak, Tadeusz; Brown, Jennifer R; Kahl, Brad S; Ghia, Paolo; Giannopoulos, Krzysztof; Šimkovič, Martin; Österborg, Anders; Laurenti, Luca; Walker, Patricia A; Opat, Stephen S; Ciepluch, Hanna; Greil, Richard; Hanna, Merit; Tani, Monica; Trněný, Marek; Brander, Danielle; Flinn, Ian W; Grosicki, Sebastian; Verner, Emma; Tedeschi, Alessandra; de Guibert, Sophie; Tumyan, Gayane; Laribi, Kamel; García-Marco, José A; Li, Jian-Yong; Tian, Tian; Liu, Yu; Korolkiewicz, Roman; Szeto, Andy; Tam, Constantine S; Jurczak, Wojciech

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

RESONATE-2 研究的最终分析:对慢性淋巴细胞白血病/小淋巴细胞淋巴瘤一线伊布替尼治疗进行长达 10 年的随访。

Burger, Jan A; Barr, Paul M; Robak, Tadeusz; Owen, Carolyn; Tedeschi, Alessandra; Sarma, Anita; Patten, Piers E M; Grosicki, Sebastian; McCarthy, Helen; Offner, Fritz; Szafer-Glusman, Edith; Zhou, Cathy; Szoke, Anita; Neumayr, Lynne; Dean, James P; Ghia, Paolo; Kipps, Thomas J

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL

MURANO 研究:VenR 治疗复发/难治性 CLL 患者的最终分析和再治疗/交叉亚组研究结果

Kater, Arnon P; Harrup, Rosemary; Kipps, Thomas J; Eichhorst, Barbara; Owen, Carolyn J; Assouline, Sarit; Lamanna, Nicole; Robak, Tadeusz; de la Serna, Javier; Jaeger, Ulrich; Cartron, Guillaume; Montillo, Marco; Mellink, Clemens; Langerak, Anton W; Chyla, Brenda; Popovic, Relja; Jiang, Yanwen; Millen, Rosemary; Lefebure, Marcus; Thadani-Mulero, Maria; Boyer, Michelle; Seymour, John F

Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial

阿卡替尼联合苯达莫司汀和利妥昔单抗治疗初治或复发/难治性套细胞淋巴瘤患者的安全性和有效性:Ib期试验

Phillips, Tycel; Wang, Michael; Robak, Tadeusz; Gallinson, David; Stevens, Don; Patel, Krish; Ramadan, Safaa; Wun, Chuan-Chuan; Jurczak, Wojciech; Smith, Stephen D

Double Strike in Chronic Lymphocytic Leukemia-The Combination of BTK and BCL2 Inhibitors in Actual and Future Clinical Practice

慢性淋巴细胞白血病的双重打击——BTK 和 BCL2 抑制剂联合治疗在实际和未来临床实践中的应用

Zygmunciak, Przemyslaw; Dancewicz, Hanna; Stróżna, Katarzyna; Błażowska, Olga; Bieliński, Krzysztof; Robak, Tadeusz; Puła, Bartosz

The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs

靶向药物时代慢性淋巴细胞白血病新型疗法的研发

Robak, Tadeusz; Iskierka-Jażdżewska, Elżbieta; Puła, Anna; Robak, Pawel; Puła, Bartosz

A rare case of Rosai-Dorfman disease mimicking a malignant lymphoproliferative process and IgG4-related disease

一例罕见的罗赛-多夫曼病病例,其临床表现酷似恶性淋巴增生性疾病和IgG4相关疾病。

Czerwiński, Jakub; Pysiewicz, Mateusz; Sołek, Julia Maria; Opinc, Aleksandra; Robak, Tadeusz; Makowska, Joanna; Braun, Marcin

Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group

更正:加速型慢性淋巴细胞白血病——波兰成人白血病研究组的特征和回顾性分析

Sośnia, Oktawia; Iskierka-Jażdżewska, Elżbieta; Puła, Anna; Wiśniewski, Kamil; Drozd-Sokołowska, Joanna; Morawska, Marta; Gosik, Urszula; Woszczyk, Dariusz; Ogłoza, Agata; Wdowiak, Kamil; Paszkiewicz-Kozik, Ewa; Wąsik-Szczepanek, Ewa; Markiewicz, Mirosław; Zawartko, Magdalena; Kokoć, Anna; Szumera-Ciećkiewicz, Anna; Prochorec-Sobieszek, Monika; Jesionek-Kupnicka, Dorota; Braun, Marcin; Gierej, Beata; Robak, Tadeusz; Lech-Marańda, Ewa; Puła, Bartosz